News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
565,686 Results
Type
Article (46657)
Company Profile (119)
Press Release (518899)
Multimedia
Podcasts (141)
Webinars (19)
Section
Business (149735)
Career Advice (2419)
Deals (28519)
Drug Delivery (142)
Drug Development (70137)
Employer Resources (158)
FDA (16340)
Job Trends (12156)
News (272136)
Policy (30253)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2321)
Academic (1)
Accelerated approval (34)
Adcomms (36)
Allergies (132)
Alliances (37884)
ALS (163)
Alzheimer's disease (1708)
Antibody-drug conjugate (ADC) (312)
Approvals (16483)
Artificial intelligence (496)
Autoimmune disease (155)
Automation (32)
Bankruptcy (318)
Best Places to Work (9249)
BIOSECURE Act (23)
Biosimilars (190)
Biotechnology (69)
Bladder cancer (157)
Brain cancer (54)
Breast cancer (586)
Cancer (4513)
Cardiovascular disease (410)
Career advice (2046)
Career pathing (38)
CAR-T (260)
CDC (59)
Celiac Disease (1)
Cell therapy (718)
Cervical cancer (35)
Clinical research (60098)
Collaboration (1484)
Company closure (4)
Compensation (1147)
Complete response letters (72)
COVID-19 (2724)
CRISPR (86)
C-suite (767)
Cystic fibrosis (141)
Data (5750)
Decentralized trials (2)
Denatured (32)
Depression (146)
Diabetes (478)
Diagnostics (5599)
Digital health (34)
Diversity (7)
Diversity, equity & inclusion (43)
Drug discovery (221)
Drug pricing (221)
Drug shortages (33)
Duchenne muscular dystrophy (235)
Earnings (63449)
Editorial (65)
Employer branding (20)
Employer resources (142)
Events (83422)
Executive appointments (887)
FDA (19390)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (20)
Funding (1272)
Gene editing (192)
Generative AI (43)
Gene therapy (603)
GLP-1 (1062)
Government (4194)
Grass and pollen (8)
Guidances (376)
Healthcare (14975)
HIV (56)
Huntington's disease (49)
IgA nephropathy (84)
Immunology and inflammation (284)
Immuno-oncology (58)
Indications (94)
Infectious disease (2979)
Inflammatory bowel disease (181)
Inflation Reduction Act (14)
Influenza (105)
Intellectual property (233)
Interviews (453)
IPO (14190)
IRA (57)
Job creations (3212)
Job search strategy (1672)
JPM (66)
Kidney cancer (16)
Labor market (81)
Layoffs (617)
Leadership (39)
Legal (7088)
Liver cancer (90)
Longevity (12)
Lung cancer (597)
Lymphoma (353)
Machine learning (40)
Management (52)
Manufacturing (731)
MASH (165)
Medical device (11698)
Medtech (11741)
Mergers & acquisitions (15322)
Metabolic disorders (1305)
Multiple sclerosis (144)
NASH (22)
Neurodegenerative disease (322)
Neuropsychiatric disorders (96)
Neuroscience (2903)
Neurotech (1)
NextGen: Class of 2026 (5021)
Non-profit (3206)
Now hiring (30)
Obesity (655)
Opinion (277)
Ovarian cancer (152)
Pain (190)
Pancreatic cancer (214)
Parkinson's disease (275)
Partnered (26)
Patents (474)
Patient recruitment (448)
Peanut (53)
People (44957)
Pharmaceutical (33)
Pharmacy benefit managers (32)
Phase 1 (18018)
Phase 2 (26020)
Phase 3 (21211)
Pipeline (4899)
Policy (332)
Postmarket research (2288)
Preclinical (7374)
Press Release (30)
Prostate cancer (238)
Psychedelics (54)
Radiopharmaceuticals (244)
Rare diseases (874)
Real estate (4418)
Recruiting (65)
Regulatory (23416)
Reports (40)
Research institute (2120)
Resumes & cover letters (403)
Rett syndrome (27)
RNA editing (16)
RSV (72)
Schizophrenia (151)
Series A (217)
Series B (178)
Service/supplier (8)
Sickle cell disease (96)
Special edition (25)
Spinal muscular atrophy (140)
Sponsored (46)
Startups (2907)
State (1)
Stomach cancer (20)
Supply chain (104)
Tariffs (101)
The Weekly (108)
Vaccines (1084)
Venture capital (94)
Weight loss (463)
Women's health (72)
Worklife (22)
Date
Today (105)
Last 7 days (567)
Last 30 days (1982)
Last 365 days (28271)
2026 (2808)
2025 (28498)
2024 (31520)
2023 (35125)
2022 (45214)
2021 (48734)
2020 (45738)
2019 (36455)
2018 (27643)
2017 (28063)
2016 (26021)
2015 (28345)
2014 (22072)
2013 (18002)
2012 (19324)
2011 (19995)
2010 (18443)
Location
Africa (696)
Alabama (67)
Alaska (6)
Arizona (233)
Arkansas (10)
Asia (32876)
Australia (5832)
California (10342)
Canada (2531)
China (915)
Colorado (408)
Connecticut (455)
Delaware (311)
Europe (80355)
Florida (1573)
Georgia (317)
Hawaii (4)
Idaho (40)
Illinois (742)
India (53)
Indiana (421)
Iowa (22)
Japan (399)
Kansas (104)
Kentucky (25)
Louisiana (19)
Maine (73)
Maryland (1283)
Massachusetts (7507)
Michigan (267)
Minnesota (551)
Mississippi (5)
Missouri (116)
Montana (12)
Nebraska (22)
Nevada (110)
New Hampshire (60)
New Jersey (2787)
New Mexico (16)
New York (2680)
North Carolina (1344)
North Dakota (7)
Northern California (5126)
Ohio (283)
Oklahoma (16)
Oregon (34)
Pennsylvania (1993)
Puerto Rico (18)
Rhode Island (32)
South America (1054)
South Carolina (63)
South Dakota (1)
Southern California (4020)
Tennessee (148)
Texas (1540)
United States (36257)
Utah (263)
Virginia (242)
Washington D.C. (73)
Washington State (826)
West Virginia (4)
Wisconsin (109)
Wyoming (1)
565,686 Results for "edap tms s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance
January 12, 2026
·
7 min read
Press Releases
EDAP to Participate in the UBS Global Healthcare Conference
October 27, 2025
·
1 min read
Press Releases
EDAP to Present at Piper Sandler 37th Annual Healthcare Conference
November 19, 2025
·
1 min read
Press Releases
EDAP to Present at Jefferies Global Healthcare Conference 2025 in London
November 4, 2025
·
1 min read
Press Releases
EDAP Reports Third Quarter 2025 Financial Results
November 7, 2025
·
15 min read
Press Releases
EDAP Receives HIFU Reimbursement for Prostate Cancer in France
September 8, 2025
·
5 min read
Press Releases
EDAP Reports Strong Second Quarter 2025 HIFU Results
August 29, 2025
·
15 min read
Press Releases
EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU
October 21, 2025
·
5 min read
Press Releases
EDAP to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
August 25, 2025
·
1 min read
Business
EDAP Reports First Quarter 2024 Financial Results
EDAP TMS SA, the global leader in robotic energy-based therapies, reported unaudited financial results for the first quarter of 2024.
May 16, 2024
·
15 min read
1 of 56,569
Next
